DelveInsight

DelveInsight is a prominent provider of valuable research within biotech and pharmaceutical industries. It offers analytical reports in such Health Care sectors as gene therapy, medical oncologic therapy, Active Pharmaceutical Ingredient (API) manufacturing, stem cell medication, biosimilars, orphan drugs and others. The expertise includes:
  • Company’s profile and licensing data;
  • New technology studies;
  • Biologic benchmarking;
  • Treatment modality analysis;
  • Competitive landscape;
  • Product assessment; etc.
This knowledge is essential for Generic and Drug Development companies, which also receive drug sales estimation and product performance forecasts.

DelveInsight reconciles customers need for information and for innovative approaches in business development. Consequently, the obtained data is turned into strategic design, partner up opportunities, profit earning capacity of the business. DelveInsight analysts assist pharma enterprises in launching new products and marketing development of existing pharmaceutics.


Research Reports By DelveInsight

Found 2347 publications
Narcolepsy - Pipeline Insight, 2018 US$ 1,250.00 Jun, 2018 76 pages
Epilepsy -Epidemiology Forecast to 2027 US$ 3,250.00 Jun, 2018 50 pages
Xyrem - API Insight, 2018 US$ 500.00 Jun, 2018 33 pages
Wet AMD- Pipeline Insight, 2018 US$ 1,500.00 Jun, 2018 106 pages
Herpes Simplex -Epidemiology Forecast to 2027 US$ 3,250.00 Jun, 2018 70 pages
Primary Biliary Cirrhosis - Pipeline Insight, 2018 US$ 1,250.00 Jun, 2018 61 pages
Hepatitis D - Epidemiology Forecast to 2027 US$ 3,250.00 Jun, 2018 60 pages
Opioid Receptor Antagonists- Pipeline Insight, 2018 US$ 1,500.00 Jun, 2018 99 pages
Retinal Degeneration - Pipeline Insight, 2018 US$ 1,500.00 Jun, 2018 217 pages
CD40 Agonist - Pipeline Insight, 2018 US$ 1,250.00 Jun, 2018 79 pages
Neuroblastoma (NB)- Epidemiology Forecast to 2027 US$ 3,250.00 Jun, 2018 60 pages
Endometriosis- Epidemiology Forecast to 2027 US$ 3,250.00 Jun, 2018 50 pages
Eosinophilic Esophagitis- Pipeline Insight, 2018 US$ 1,250.00 Jun, 2018 63 pages
Entyvio- Drug Insight, 2018 US$ 1,000.00 Jun, 2018 39 pages
Multiple Sclerosis  -Epidemiology Forecast to 2027 US$ 3,250.00 Jun, 2018 102 pages
1 2 3 4 5 ... 47
Skip to top

Analytics & News by DelveInsight